Why the study?
Does the Navitor valve improve 5-year clinical outcomes, hemodynamic performance, and durability in patients with symptomatic, severe aortic stenosis at high or extreme surgical risk?
Cohort
Does the Navitor valve improve 5-year clinical outcomes, hemodynamic performance, and durability in patients with symptomatic, severe aortic stenosis at high or extreme surgical risk?
The Navitor valve is a next-generation self-expanding and intra-annular transcatheter aortic valve designed to minimize paravalvular leak (PVL) with an active sealing cuff. The aim of this analysis is to present the most updated 5-year clinical outcomes, hemodynamic performance, and durability of the Navitor valve in patients with symptomatic, severe aortic stenosis (AS) at high or extreme surgical risk from the Navitor IDE study.
No takes yet. Share an insight, caveat, or question.
Dustin Kliner (2026) conducted a cohort in symptomatic, severe aortic stenosis (AS) at high or extreme surgical risk. Navitor valve was evaluated on 5-year clinical outcomes, hemodynamic performance, and durability.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: